CCSAX
Price
$12.82
Change
-$0.16 (-1.23%)
Updated
Sep 11 closing price
Net Assets
473.62M
PCRAX
Price
$15.40
Change
-$0.27 (-1.72%)
Updated
Sep 11 closing price
Net Assets
4.72B
Interact to see
Advertisement

CCSAX vs PCRAX

CCSAX vs PCRAX Comparison Chart in %
View a ticker or compare two or three
VS
CCSAX vs. PCRAX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCSAX is a Hold and PCRAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PCRAX has more cash in the bank: 4.72B vs. CCSAX (474M). PCRAX pays higher dividends than CCSAX: PCRAX (11.45) vs CCSAX (2.18). CCSAX was incepted earlier than PCRAX: CCSAX (14 years) vs PCRAX (24 years). PCRAX (1.56) is less costly to investors than CCSAX (1.11). PCRAX is a more actively managed with annual turnover of: 224.00 vs. CCSAX (124.00). CCSAX (6%) and PCRAX (6%) have equivalent initial investment costs. PCRAX has a lower initial minimum investment than CCSAX: PCRAX (1000) vs CCSAX (2000). CCSAX (45.59) and PCRAX (43.88) have marching annual gain over last year. CCSAX return over 5 years is better than : 85.36 vs. PCRAX (66.93).
CCSAXPCRAXCCSAX / PCRAX
Total Expense Ratio1.111.4378%
Annual Report Gross Expense Ratio1.111.5671%
Fund Existence14 years24 years-
Gain YTD37.25935.026106%
Front Load6%6%105%
Min. Initial Investment20001000200%
Min. Initial Investment IRAN/A1000-
Net Assets474M4.72B10%
Annual Yield % from dividends2.1811.4519%
Returns for 1 year45.5943.88104%
Returns for 3 years57.8953.47108%
Returns for 5 years85.3666.93128%
Returns for 10 years129.37125.01103%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NASDX52.850.47
+0.90%
Shelton Nasdaq-100 Index Investor
FCAGX38.20N/A
N/A
Fidelity Advisor Small Cap Growth A
ACMDX11.72N/A
N/A
Absolute Capital Defender Investor
ECHSX13.21N/A
N/A
Eaton Vance Worldwide Health Sci C
SVIIX10.48N/A
N/A
Virtus Ceredex Large-Cap Value Equity A